Alimera Sciences RPE

RPE a Health Care szektor a NASDAQ-on cégekben a Alimera Sciences -hoz képest

Mit csinál Alimera Sciences?

alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.

rpe -hoz hasonló cégek Alimera Sciences

• Coveo Solutions nak RPE $204.448k van
• Verint Systems nak RPE $204.498k van
• Nacon S.A nak RPE €204.512k van
• MJ Hudson plc nak RPE £204.526k van
• ConvaTec Plc nak RPE $204.575k van
• Shield Therapeutics Plc nak RPE £204.600k van
• Alimera Sciences nak RPE $204.684k van
• Société BIC SA nak RPE €204.760k van
• Metals Exploration plc nak RPE $204.791k van
• Edenred SA nak RPE €204.929k van
• Coherent Corp nak RPE $204.958k van
• Calibre Mining nak RPE $205.044k van
• Credit Corp nak RPE AUD$205.326k van